Skip to main content
. 2022 Feb 10;12:836517. doi: 10.3389/fonc.2022.836517

Figure 1.

Figure 1

Effects of HBx combo mutations on HCC occurrence in a prospective cohort study with 2114 HBV-infected patients. (A) Effect of A1762T/G1764A+C1653T+T1674G on HCC occurrence. (B) Effect of A1762T/G1764A+T1674G+T1753C on HCC occurrence. (C) Effect of A1762T/G1764A+C1653T+T1753C on HCC occurrence. Hazard ratio (HR) was adjusted with age and gender.